Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients

Proceedings of the National Academy of Sciences of the United States of America

Volumn 90, Issue 1, 1993, Pages 25-29

  Mohri, H ^a   Singh, M K ^a   Ching, W T W ^a   Ho, D D ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD; BLOOD TOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE CALCULATION; DRUG MECHANISM; DRUG RESISTANCE; ENZYME STRUCTURE; FEMALE; GASTROINTESTINAL SYMPTOM; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS ISOLATION; VIRUS RESISTANCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED COMPLEX; AMINO ACID SEQUENCE; DRUG RESISTANCE, MICROBIAL; FEMALE; HIV SEROPOSITIVITY; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMAN; MALE; MOLECULAR SEQUENCE DATA; MUTATION; RNA-DIRECTED DNA POLYMERASE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; ZIDOVUDINE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0027459081     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.90.1.25     Document Type: Article

References (0)